Levamisole for children with nephrotic syndrome: new evidence for the use of an "old" drug.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 30606425.
- Also identified by DOI 10.1016/j.kint.2018.10.008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the current issue of Kidney International, Sinha et al. report results of a randomized controlled trial comparing levamisole and mycophenolate mofetil for the second-line treatment of children with frequent relapses of nephrotic syndrome. This study suggests that these two agents may both be safe and effective. The present commentary addresses strengths and limitations of this important study.
Medical subject headings
- Mycophenolic Acid
- Nephrotic Syndrome